Hyperglycemia caused reduction of cortical bone thickness in streptozotocin-induced diabetic rat

Maria Cellina Wijaya and Gadis Meinar Sari and Damayanti Tinduh (2016) Hyperglycemia caused reduction of cortical bone thickness in streptozotocin-induced diabetic rat. Bali Medical Journal, 6 (1). pp. 161-163. ISSN 2089-1180

[img] Text (Peer Review)
Hyperglycemia Caused reduction of cortical bone.pdf

Download (2MB)
[img] Text (Similarity)
Hyperglycemia caused reduction of cortical bone thickness in streptozotocin-induced diabetic rat.pdf

Download (1MB)
[img] Text (Artikel)
Hyperglycemia caused reduction of cortical bone thickness in streptozotocin-induced diabetic rat.pdf

Download (2MB)
Official URL: https://www.balimedicaljournal.org/index.php/bmj/a...

Abstract

Background: Diabetes is a chronic metabolic disease characterized by hypergyclemia due to insulin deficiency (type 1 diabetes) or insulin insensitivity/resistance (type 2 diabetes). The significant metabolic changes that occur in diabetes also affect the skeleton and cause bone loss and/or altered bone matrix and strength, thereby increasing the risk of fracture. Hyperglycemia can alter cellular metabolic processes through the formation of advanced glycation end products (AGEs), which caused dysregulation of various cytokines as the underlying mechanism in the decrease of bone density. This study aimed to see the bone loss caused by hyperglycemia in rats, using cortical bone thickness as a parameter. Methods: This study was an analytical experimental study, which was conducted in a laboratory. The sample of this study was Wistar rat (Rattus norvegicus). Diabetes in the rats were induced using streptozotocin. The diabetic rats were then sacrificed 11 days later, and the left femur bone was obtanied. The bone was decalcified for 1 week, then prepared for histological slides. Cortical bone thickness was measured microscopically using Optilab Image Raster software at 10 different axis points, and then averaged. Results: The mean of cortical bone thickness were 32.43 ± 2.65 μm in the control (non diabetic) rats, and 26.64 ± 2.89 μm in streptozotocin-induced diabetic rats (p < 0.001). The diabetic rats had lower mean of cortical bone thickness than control by 5.79 μm. Conclusion: Cortical bone thickness in the diabetic rats were lower by 18% compared to control 11 days after induction of streptozotocin.

Item Type: Article
Uncontrolled Keywords: hyperglycemia, diabetes, bone, cortical bone thickness, streptozotocin, rat
Subjects: R Medicine > R Medicine (General)
R Medicine > RZ Other systems of medicine
Divisions: 01. Fakultas Kedokteran > Ilmu Faal
Creators:
CreatorsNIM
Maria Cellina WijayaNIM011311133026
Gadis Meinar SariNIDN0004056612
Damayanti TinduhNIDN8889900016
Depositing User: arys fk
Date Deposited: 26 Feb 2020 01:45
Last Modified: 26 Feb 2020 01:45
URI: http://repository.unair.ac.id/id/eprint/94501
Sosial Share:

Actions (login required)

View Item View Item